What Happens When a Problem Solver Becomes a Doctor | Dr. Andrew Pecora

He turned down offers from ‪@mskcc‬ and ‪@WeillCornell‬ to go back to New Jersey — because New Jersey didn’t have bone marrow transplant, and he decided he was going to build it. He did. Then he led the first human trial of an intravenous oncolytic virus. Then he built ‪@johntheurercancercenter4106‬ from a single infusion chair into the 38th-ranked cancer center in the country. Then he founded one of the largest oncology physician networks in America. Then he ran the physician enterprise of a $7 billion health system. Then he spoke at the Vatican. Twice. That is the story of Dr. Andrew Pecora — hematologist, oncologist, stem cell transplant pioneer, and founder and CEO of OMI Management. In this episode of The Moonlight Shift, he sits down to talk about what drives someone who has never accepted that a lane exists. In this episode: — “New Jersey didn’t have bone marrow transplant. So I went home and built it.” — The first time an IV oncolytic virus was ever given to a human being — and what happened next — Hiring the Ritz Carlton and Walt Disney to design a cancer center — Building RCCA: why community oncologists had no market clout — and how that changed — OMI Management: using AI to show physicians the cost of care at the point of care, in real time — “The best people to control the cost of care are the physicians delivering it.” — Speaking at the Vatican on stem cell policy — and what the Church actually wanted to know — Disrupt or Preserve: five statements about how oncology works today Hosted by Gina Mauro, Executive Director, Oncology Ambassador, MJH Life Sciences. The Moonlight Shift — The conversation after the podium clears. Subscribe for new episodes every two weeks. Full episodes on ‪@OncLiveTV‬, ‪@Targetedonc‬, ‪@CancerNetwork‬, ‪@curetoday‬ and Oncology Nursing News. #Oncology #Hematology #TheMoonlightShift #MJHLifeSciences #StemCellTransplant #OncolyticVirus #HealthcareInnovation #CancerCare #HackensackMeridian